Iatia Widens Your Scope

Victoria, Australia-based IATIA Ltd., in conjunction with the University of Melbourne, has commercialized a versatile and highly cost-effective way to dramatically enhance the capabilities of conventional light microscopes. Quantitative Phase Microscopy (QPm) enables a standard bright field microscope to perform tasks usually handled by several different, specialized instruments. QPm is the brainchild of University of Melbourne physics professor Keith Nugent, whose proprietary algorithm based on

Written byWendy Gloffke
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

QPm is the brainchild of University of Melbourne physics professor Keith Nugent, whose proprietary algorithm based on the Transport of Intensity equation1 processes amplitude and phase data from a sample. This technology provides independent digital acquisition of both quantitative phase and amplitude (intensity) information. The result is a set of "virtual" images that previously required several different instruments to obtain. For example, researchers can obtain differential interface contrast, dark field, Zernike phase contrast, and Hoffman modulation visualizations from a standard bright field instrument. In short, QPm allows researchers to expand analytical capabilities with relatively modest resource and personnel allocations.

In QPm, a phase tube and a 10-bit or greater research grade digital camera are attached to the microscope to capture the in-focus image and images above and below the focal plane. The accompanying software then processes phase difference information using Nugent's Quantitative Phase algorithm. Contrast-enhancing stains are not required.

Computer-generated ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies